Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome
Clinical trial NCT05379166 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05379166
- Sponsor
- Uma Borate
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-23
- Primary completion
- 2026-01-27
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.